MétaCan
Menu
Back to cohort
Record W4405041772 · doi:10.1182/blood-2024-199172

Imaging Predictors of Intracerebral Hemorrhage in Patients with Brain Tumors Treated with Anticoagulation

2024· article· en· W4405041772 on OpenAlexaff
Rani Barnea, Jonathan Naftali, Eva N. Hamulyák, Andrew M. Peseski, Tzu‐Fei Wang, Lisa Baumann Kreuziger, Varun Iyengar, Brian J. Carney, Berna C. Özdemir, Kristen M. Sanfilippo, Shira Rozenblatt, Ludo F.M. Beenen, Shlomit Yust‐Katz, Erez Halperin, Aaron Lubetsky, Andriy Derkach, David Nemirovsky, Marc Carrier, Ben Massat, Ariela Arad, Martinus P. G. Broen, Gabriela N. Cesarman-Maus, Ann Hoeben, Michèle J. Hoffmann, Yossi Kalish, Pia Raanani, Hugo Ten Cate, Ariella Tvito, Harry R. Büller, Galia Spectre, Jeffrey I. Zwicker, Eitan Auriel, Avi Leader

Bibliographic record

VenueBlood · 2024
Typearticle
Languageen
FieldMedicine
TopicBrain Metastases and Treatment
Canadian institutionsOttawa HospitalUniversity of Ottawa
Fundersnot available
KeywordsMedicineIntracerebral hemorrhageGliomaInternal medicineRadiologySubarachnoid hemorrhage

Abstract

fetched live from OpenAlex

Introduction Spontaneous intracerebral hemorrhage (sICH) frequently occurs in patients with primary or metastatic brain tumors treated with anticoagulation and presents primarily as intratumoral bleeding. While an association between the burden of cerebral small vessel disease (CSVD) on brain magnetic resonance imaging (MRI) and sICH has been observed in patients receiving anticoagulation, it is unknown whether this holds true for patients with brain tumors. Intratumoral siderosis, a marker of prior subclinical sICH, represents a potential risk factor for subsequent sICH. Aim To evaluate whether markers of CSVD on brain MRI and intratumoral siderosis are associated with sICH in patients with brain tumors treated with anticoagulation. Methods This was a preplanned sub-study of the ABC study, a retrospective multinational cohort study which included 745 adults with primary or metastatic brain tumors treated with therapeutic-dose anticoagulation (low molecular weight heparin [LMWH] or direct oral anticoagulant [DOAC]) for any indication or duration (1/1/2014 - 1/1/2022), with 12 month follow up. All patients in whom baseline MRI images were available were included in the current study. MRI scans were analyzed for imaging markers of CSVD that are known to be independently associated with sICH in the general population, including white matter hyperintensities graded by Fazekas score (to reflect CSVD burden) and cerebral microbleeds. Baseline MRI scans were read and analyzed according to STRIVE-2 classification by a neurovascular research group specialized in CSVD imaging with excellent interrater reliability for these measures (Naftali 2023. PMID: 37978833). Intratumoral siderosis were also analyzed. The study outcome was sICH over 12 months follow-up, identified by record review and confirmed by a neuroradiologist, who was blinded to baseline MRIs. Baseline MRI readers were blinded to occurrence of sICH outcomes during follow up. Univariate analysis assessed associations between baseline MRI parameters and sICH, stratified for study center and adjusted for stopping anticoagulation. An additional analysis adjusted for cancer type as well. Results This analysis included 294 with baseline MRI of the 745 ABC patients. The median age was 63.0 years and 148 (50%) were female. Cancer types included primary brain tumors (123; 42.0%), metastases from primary lung (105; 36.0%), breast (29; 9.9%), and melanoma grouped with renal cell carcinoma tumors (12; 4.1%), as well as other types of cancer (25; 8.5%). The indication for anticoagulation was venous thromboembolism in 265 (90%) patients; 169 (57.5%) patients were treated with LMWH and 125 (42.5%) were treated with a DOAC. The 12-month cumulative incidence of sICH was 7.9% (95% confidence interval [CI] 5.3%-12.0%); 20/22 sICH events were intratumoral. The baseline MRI was performed at a median of 14 days (IQR 0-39) before study index date (i.e., first day of concurrent anticoagulation and brain tumor). Cerebral microbleeds and intratumoral siderosis could be assessed in the 224/294 patients with susceptibility weighted imaging (SWI) sequences performed. Fazekas score could be evaluated in the 290/294 patients with fluid attenuated inversion recovery (FLAIR) sequences. Nineteen of 224 (8.5%) patients had extratumoral cerebral microbleeds. Intratumoral siderosis was demonstrated in 83/224 (37%) patients. The Fazekas score was 0 or 1 (no or mild CSVD burden) in 261/290 (90%) patients and 2 or 3 (moderate to severe CSVD burden) in 29/290 (10%) patients. On univariable analysis, intratumoral siderosis (hazard ratio [HR] 3.44; 95% CI 1.01-11.7); cerebral microbleeds (HR 8.13; 95% CI 1.81-36.6) and moderate to severe CSVD burden (HR 4.71; 95% CI 1.89-11.7) were associated with sICH. Adjustment for cancer type demonstrated similar associations for intratumoral siderosis (HR 2.59; 95% CI 0.70-9.67), cerebral microbleeds (HR 11.4; 95% CI 1.71 - 76.1) and moderate to severe CSVD burden (HR 5.28; 95% CI 1.94 - 14.4). In a cross-correlation analysis, no statistically significant associations between the 3 MRI parameters were observed at baseline. Conclusion Baseline MRI findings appear to be predictive of sICH in patients with brain tumors treated with anticoagulation. Future studies should assess whether these parameters can guide management of anticoagulation in this population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.213
Teacher spread0.208 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueBloodSame topicBrain Metastases and TreatmentFrench-language works237,207